Robert Lanza
Impact in
- Molecular Biology top 0.5%
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- Retinal Development and Disorders
- Renal and related cancers
- Ophthalmology top 0.5%
Papers in
-
- Pluripotent Stem Cells Research 48
- CRISPR and Genetic Engineering 28
- Retinal Development and Disorders 14
- Renal and related cancers 13
- Surgery 56
- Pancreatic function and diabetes 38
- Co-authors
- Irina Klimanskaya (15 shared papers)Michael D. West (17 shared papers)William L. Chick (25 shared papers)Erin A. Kimbrel (14 shared papers)Anthony Atala (10 shared papers)Young Sun Chung (9 shared papers)Shi‐Jiang Lu (16 shared papers)José B. Cibelli (9 shared papers)
- Journals
- Transplantation (6 papers)Regenerative Medicine (6 papers)Science (5 papers)Nature (5 papers)The Lancet (4 papers)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Robert Lanza
140 papers receiving 13.4k citations
Robert Lanza's Hit Papers
Peers
Comparison fields: 5 of 182
- Molecular Biology 9.1k
- Ophthalmology 844
- Genetics 1.0k
- Developmental Neuroscience 340
- Surgery 3.1k
Countries citing papers authored by Robert Lanza
This map shows the geographic impact of Robert Lanza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lanza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lanza more than expected).
Fields of papers citing papers by Robert Lanza
This network shows the impact of papers produced by Robert Lanza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lanza. The network helps show where Robert Lanza may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Lanza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 146 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins Hit paper breakdown → | 2009 | 1281 |
| 2 | Embryonic stem cell trials for macular degeneration: a preliminary report Hit paper breakdown → | 2012 | 1023 |
| 3 | Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies Hit paper breakdown → | 2014 | 937 |
| 4 | 1977 | 375 | |
| 5 | 2009 | 349 | |
| 6 | 2000 | 344 | |
| 7 | 2006 | 343 | |
| 8 | Methods of tissue engineering | 2002 | 342 |
| 9 | 2004 | 311 | |
| 10 | 2008 | 298 | |
| 11 | 2006 | 296 | |
| 12 | 2015 | 285 | |
| 13 | 2010 | 279 | |
| 14 | 2000 | 265 | |
| 15 | 1984 | 255 | |
| 16 | 2005 | 242 | |
| 17 | 2002 | 223 | |
| 18 | 2005 | 221 | |
| 19 | 2020 | 216 | |
| 20 | 2008 | 214 |
About Robert Lanza
Robert Lanza is a scholar working on Molecular Biology, Surgery, Genetics, Endocrinology, Diabetes and Metabolism and Genetics, having authored 146 papers that have together received 14.1k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (48 papers), Pancreatic function and diabetes (38 papers), CRISPR and Genetic Engineering (28 papers), Diabetes and associated disorders (14 papers), Retinal Development and Disorders (14 papers), Renal and related cancers (13 papers), Diabetes Management and Research (12 papers) and Mesenchymal stem cell research (10 papers). The work is most often cited by research in Molecular Biology (9.1k citations), Ophthalmology (844 citations), Genetics (1.0k citations), Developmental Neuroscience (340 citations) and Surgery (3.1k citations). Robert Lanza has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Irina Klimanskaya, Michael D. West, William L. Chick, Erin A. Kimbrel, Anthony Atala, Young Sun Chung, Shi‐Jiang Lu, José B. Cibelli, Dohoon Kim and Steven D. Schwartz. Their work appears in journals such as Transplantation, Regenerative Medicine, Science, Nature and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.